RNA Message Levels in Normally Aging and in Alzheimer’s Disease(AD)-Affected Human Temporal Lobe Neocortex

  • Walter J. Lukiw
  • Donald R. McLachlan
  • Nicolas G. Bazan
Part of the GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia book series (GWUN)


The expression of genetic information in neurons and glia, as in all eukaryotic cells, is dependent upon a hierarchy of control, from the acquisition of a transcriptionally competent chromatin conformation to the final assembly and compartmentalization of the relevant gene products. As outlined in Table 1, this genetic signal transduction pathway from DNA to RNA to protein can be further categorized into a series of control gates involving DNA transcription and other post-transcriptional aspects of gene regulation (1–6) and (b) a series of translational and post-translational control points (8–12); the shuttling of RNA messages out of the nucleus and into the cytoplasm represents one prominent intermediary control point (7). Amongst the eukaryotic cells, neurons of the mammalian brain appear to be unique in that the rate of genetic information flow through these control gates appears to be particularly rapid1, and both quantitatively and qualitatively large amounts of brainspecific DNA transcription products are generated1,2.


Growth Inhibitory Factor Primary Gene Product Temporal Lobe Neocortex Numerous Senile Plaque Packard Instant Imager 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R.J. Thompson, Studies on RNA synthesis in two populations of nuclei from the mammalian cerebral cortex, J. Neurochem. 21: 19 (1973).PubMedCrossRefGoogle Scholar
  2. 2.
    W.J. Lukiw, P. Handley, L. Wong, and D.R.C. McLachlan, BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD) and senile dementia of the Alzheimer type (AD), Neurochem Res. 17:591 (1992).PubMedCrossRefGoogle Scholar
  3. 3.
    S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, L. Berg, and participating CERAD neuropathologists, The consortium to establish a registry for Alzheimer’s disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease, Neurology 41:479 (1991).PubMedCrossRefGoogle Scholar
  4. 4.
    W.J. Lukiw, N.G. Bazan, and D.R.C. McLachlan, Relative RNA message abundance in control and Alzheimer’s disease-affected human neocortex, in: “Research Advances in Alzheimer’s Disease and Related Disorders” K. Iqbal, J.A. Mortimer, B. Winblad and H.M. Wisniewski, eds., John Wiley & Sons Ltd, New York (1995).Google Scholar
  5. 5.
    P. Chomzynski, A reagent for the single step-simultaneous isolation of RNA, DNA and proteins from cell and tissue samples, Biotechniques 15:532 (1993).Google Scholar
  6. 6.
    H. Tiedge, W. Chen, and J. Brosius, Primary structure, neural specific expression, and dendritic location of human BC200 RNA, J. Neurosci. 13:2382 (1993).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Walter J. Lukiw
    • 1
    • 2
  • Donald R. McLachlan
    • 1
  • Nicolas G. Bazan
    • 2
  1. 1.Centre for Research in Neurodegenerative DiseaseUniversity of TorontoTorontoCanada
  2. 2.LSU Neuroscience CenterLouisiana State University School of MedicineNew OrleansUSA

Personalised recommendations